UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000014314
Receipt No. R000016615
Scientific Title A phase II study of maintenance bevacizumab plus docetaxel following induction chemotherapy with cisplatin, pemetrexed plus bevacizumab for advanced non-squamous non-small-cell lung cancer
Date of disclosure of the study information 2014/06/19
Last modified on 2020/08/25 10:41:39

No. Disposal Last modified on Item of update
1 Insert 2014/06/19 16:11:58
2 Update 2014/06/19 16:12:56 Acronym
3 Update 2014/06/19 16:57:17 Email
4 Update 2014/06/19 19:34:14 Key inclusion criteria
Key exclusion criteria
5 Update 2016/06/22 15:55:05 Name of primary sponsor
Organization
6 Update 2016/12/22 14:44:39 Key inclusion criteria
7 Update 2017/06/21 09:07:21 Recruitment status
8 Update 2020/08/25 10:27:42 UMIN ID1
9 Update 2020/08/25 10:33:04 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
10 Update 2020/08/25 10:33:48 Date of IRB
Last follow-up date
11 Update 2020/08/25 10:39:13 Recruitment status
12 Update 2020/08/25 10:41:39 URL releasing protocol
Publication of results
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures


Contact us.